相关实验视频

Updated: Jun 19, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

迈克尔基于添加的新辅助剂用于增强癌症免疫治疗

Ruoxi Yang^1,2, Yongxiang Di^1,2, Xiaoning Song¹

¹NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, 24 TongJiaXiang, Nanjing 210009, China.

|July 25, 2024

概括

这项研究引入了一种新型的甲移植聚乙烯胺 (PC) 新辅助剂,通过改善树突细胞 (DC) 功能和抗原呈现来增强癌症免疫疗法,从而导致乳腺癌模型中T细胞透率增加.

科学领域:

免疫学免疫学免疫学
材料科学材料科学材料科学
在瘤学瘤学.

背景情况:

癌症免疫疗法面临的挑战是,树突细胞 (DC) 的抗原呈现效率低下.
免疫抑制性瘤微环境 (ITME) 进一步损害了DC功能.
受到DCs限制的抗原吸收阻碍了有效的抗瘤免疫反应.

研究的目的:

调查甲移植聚乙烯胺 (PC) 作为癌症免疫疗法的新辅助剂的潜力.
为了增强抗原捕获,DC成熟和瘤微环境中的抗原呈现.
在低免疫性乳腺癌模型中增强抗瘤免疫反应.

主要方法:

甲植入的聚乙烯胺 (PC) 纳米粒子的开发.
使用PC捕获瘤抗原并增强DC-抗原交声.
采用in situ迈克尔加法反应来耗尽细胞内谷氨,激活NLRP3炎症酶途径.
在小鼠乳腺癌模型中评估DC成熟和CD8+T细胞透.

主要成果:

PC新辅助剂有效捕获化疗期间产生的瘤抗原.
通过激活NLRP3通路,PC治疗导致显著的DC成熟 (46%).
PC触发了抗原释放和增强的抗原呈现.
在接受治疗的小鼠乳腺癌模型中,观察到CD8+ T细胞透率为53%.

结论:

肉甲移植的聚乙烯胺 (PC) 显示出作为一种新辅助剂的承诺,以克服癌症中的免疫逃避.
PC增强了DC功能和抗原呈现,从而提高了抗瘤免疫力.
这种方法提供了一个潜在的策略,以提高免疫疗法在挑战性癌症类型的疗效.

关键词:

这是一种GSH耗尽的过程.一个辅助的辅助者.捕获抗原捕获的方法癌症免疫疗法免疫疗法免疫遗传细胞死亡

更多相关视频

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...